
Jeff Tangney
About Jeff Tangney
Jeff Tangney (age 52) is Doximity’s co‑founder, Chief Executive Officer, Chair of the Board, and a director since the company’s inception in April 2010; he holds a B.S. in Economics and Math from the University of Wisconsin–Madison and an MBA from Stanford GSB . Under his tenure, revenue and net income have grown steadily, and cumulative TSR (since IPO base of $100) recovered in FY2025, though it trails the S&P 500 IT peer group . Doximity’s board is majority independent, but Tangney serves as both CEO and board chair, a dual role the company believes facilitates execution and information flow .
Revenue, earnings, and TSR snapshots:
| Metric | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Revenue ($mm) | 343.5 | 419.1 | 475.4 | 570.4 |
| Net Income ($mm) | 154.8 | 112.8 | 147.6 | 223.2 |
| Value of $100 Investment (DOCS) | 98.28 | 61.09 | 50.77 | 109.49 |
| Value of $100 Investment (Peer Group) | 110.08 | 105.07 | 153.41 | 162.45 |
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Epocrates, Inc. | Co‑founder; President & COO; EVP Sales & Marketing | 1999–2010 | Scaled a mobile medical reference app; operating and commercial leadership experience . |
| ZS Associates | Manager | 1993–1997 | Consulting/operational background preceding health tech entrepreneurship . |
External Roles
| Organization | Role | Years | Notes |
|---|---|---|---|
| — | — | — | No additional external public company board roles are described in Doximity’s 2024–2025 proxies (Tangney biography sections list none) . |
Board Governance
- Board service: Director since April 2010; currently Class I director nominated for re‑election to 2028 .
- Leadership: CEO also serves as Chair; majority of the board is independent (Spain, Yang, Benjamin, Wampler, Cabral) . Company cites a combined Chair/CEO as advantageous for unified strategy and information flow .
- Committees: Only independent directors serve on Audit (Cabral chair; Spain; Benjamin), Compensation (Spain chair; Yang; Wampler), and Nominating/Governance (Wampler chair; Yang; Benjamin) .
- Attendance: Each director attended at least 75% of board and applicable committee meetings in FY2025 .
- Employee-director pay: Employee directors receive no additional compensation for board service .
Fixed Compensation
Multi‑year CEO cash compensation:
| Component | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Base Salary ($) | 240,000 | 295,000 (raised to $300k effective 5/1/23) | 600,000 (retroactive to 4/1/24) |
| Target Cash Incentive ($) | — (no CEO cash incentive) | — (no CEO cash incentive) | 600,000 target |
| Actual Cash Incentive ($) | — | — | 1,200,000 (200% of target) |
Notes:
- FY2025 CEO short‑term incentive metrics were consolidated revenue (67% weight) and adjusted EBITDA (33%), with a 50–200% payout curve; both exceeded maximum thresholds in FY2025 .
- Company uses a pay‑for‑performance framework anchored to revenue and adjusted EBITDA .
Performance Compensation
Short‑term cash incentive (FY2025 – CEO):
| Metric | Weight | Target Range | Result | Payout Factor |
|---|---|---|---|---|
| Consolidated Revenue | 67% | $512–535–570mm (50–100–200%) | >$570mm | 200% |
| Consolidated Adjusted EBITDA | 33% | $238–244–250mm (50–100–200%) | >$250mm | 200% |
| Total | 100% | — | Max achieved | 200% → $1.2mm |
Long‑term equity (FY2025 grants and vesting):
| Award | Grant Date | Target/Grant | Performance | Vesting |
|---|---|---|---|---|
| RSUs | 10/24/2024 | 252,234 sh; target value $10.65mm | Service‑based | 18.75% on 11/15/2024; then 6.25% quarterly through 2/15/2028 |
| PSUs | 10/24/2024 | Target 84,077 sh ($3.6mm) | FY2025 revenue (67%) and adj. EBITDA (33%) payout 50–200%; achieved 200% → 168,154 PSUs certified | Vests 100% on 5/15/2027, service‐based post‑certification |
Program design and governance:
- Company emphasizes long‑term equity (RSUs; PSUs for CEO) with multi‑year vesting; no stock options were granted in FY2025 .
- Clawback policy adopted Oct 26, 2023 applies to current/former executive officers for restatement scenarios (Dodd‑Frank compliant) .
- Say‑on‑pay support was ~98.6% in 2024; the Compensation Committee made no structural changes in FY2025 as a result .
Equity Ownership & Alignment
Beneficial ownership and control (as of June 11, 2025):
| Holder | Class A Shares | Class B Shares | Total Ownership % | Total Voting % |
|---|---|---|---|---|
| Jeff Tangney | 1,915,274 | 52,942,996 (incl. trusts and personal; plus options exercisable within 60 days) | 28.9% | 76.3% |
Vested vs unvested and outstanding awards (as of 3/31/2025):
| Instrument | Status | Key Terms |
|---|---|---|
| Stock Options | 1,792,000 and 776,000 fully vested at $0.97; expire 3/28/2028 | Legacy grants; fully exercisable . |
| Stock Options | 2,187,500 exercisable / 1,562,500 unexercisable at $8.26; expire 2/15/2031 | Monthly vesting schedule continues (1/60th monthly) . |
| RSUs | 189,175 unvested (portion of 252,234 grant) | 18.75% vested 11/15/2024; 6.25% quarterly thereafter through 2/15/2028 . |
| PSUs | 168,154 awardable at 200% of target (certified); time‑based vest on 5/15/2027 | Performance met; service‑based until vest date . |
Trading, pledging, and hedging:
- Insider trading policy prohibits hedging, short selling, derivatives, margin accounts, and pledging; a one‑time exception allowed Tangney to pledge <5% of his holdings for a loan in Nov 2023; the loan was terminated and pledged shares released in May 2025 .
- Executives are encouraged to use 10b5‑1 trading plans .
Ownership guidelines and perquisites:
- Proxy does not disclose specific executive stock ownership guidelines for Tangney; perquisites were not material (> $10,000) for NEOs in FY2025; 401(k) match up to $3,000 .
Employment Terms
- CEO employment: At‑will under an April 2010 offer letter; eligibility for annual performance incentive and equity; benefits consistent with employee plans .
- Change‑in‑control: Company provides double‑trigger vesting for equity upon a change in control; plan‑level provisions allow for acceleration if awards are not assumed in a sale event .
- Severance: No specific CEO severance terms are described in the 2025 proxy (detailed severance is disclosed for other NEOs, not for CEO) .
Risk Indicators, Litigation, and Related Parties
- Legal proceedings: Securities class action and derivative suits filed beginning April 2024 regarding disclosure of user count/engagement; defendants (including CEO) intend to defend vigorously; securities case in discovery .
- Related party: Investors’ Rights Agreement includes Tangney and affiliated entities (registration rights) .
- Hedging/pledging: Company‑wide prohibition with a single historical CEO exception now terminated (see above) .
Compensation Structure Analysis
- Mix and alignment: FY2025 CEO pay blend shifted meaningfully toward performance‑linked equity (RSUs/PSUs) and introduced a results‑based cash bonus tied to revenue and adjusted EBITDA, with maximum outcomes requiring above‑plan performance; FY2025 results triggered max payout and PSU certification at 200% of target .
- Trend signals: Year‑over‑year increase in CEO base salary (to $600k) and restoration/introduction of annual cash incentive; long‑term orientation maintained via multi‑year equity vesting .
- Shareholder feedback: Very strong say‑on‑pay support (~98.6% in 2024) suggests investor acceptance of the program design .
Director Compensation (as a Director)
- Employee directors receive no additional compensation for board service .
- For context, non‑employee director policy in FY2025: $35,000 annual cash retainer; committee retainers; annual RSUs ~$200,000; initial RSUs ~$400,000; acceleration on sale events (caps apply) .
Performance & Track Record
- Multi‑year operating performance: Revenue rose from $343.5mm (FY2022) to $570.4mm (FY2025); net income rose from $154.8mm to $223.2mm over the same period .
- Market performance (since IPO base): Value of a $100 DOCS investment was $109.49 in FY2025 vs $162.45 for the S&P 500 IT peer group .
- Pay versus performance: FY2025 “compensation actually paid” to the PEO reflects equity valuation changes and strong operating outcomes; see pay‑vs‑performance table for detail .
Say‑on‑Pay & Peer Benchmarking
- Say‑on‑pay approval: Approximately 98.6% support at the 2024 annual meeting; committee made no changes to FY2025 program in response .
- Peer group methodology: Application software and healthcare tech peers; revenue $225mm–$1.2bn; market cap $1.5bn–$13bn; updated in October 2023 with Aon support .
Vesting Schedules and Potential Selling Pressure
- Near‑term RSU vesting: CEO RSUs vest 6.25% quarterly through Feb 15, 2028, creating regular settlement events .
- PSU vest: 168,154 PSUs scheduled to vest in full on May 15, 2027 (service condition), a single future settlement point .
- Recent liquidity events: FY2025 option exercises (178,334 shares; $13.23mm value realized) and stock vesting (63,059 shares; $3.55mm value realized) indicate realized gains and potential tax‑driven selling windows .
Equity Ownership & Control Considerations
- Supervoting structure: Tangney’s Class B holdings translate to ~76.3% of total voting power, with ~28.9% economic ownership, concentrating control and reducing hostile takeover risk .
- Hedging/pledging risk mitigated: Policy prohibits hedging/pledging; the one‑time CEO pledge exception was terminated with shares released in May 2025 .
Investment Implications
- Alignment: Compensation is tightly tied to revenue and adjusted EBITDA, with PSUs reinforcing pay‑for‑performance; strong 2024 say‑on‑pay support underscores investor alignment .
- Overhang and supply: Material ongoing RSU quarterly vesting through 2028 and a large 2027 PSU vest could create periodic supply; FY2025 exercises/vesting show CEO liquidity events to monitor around trading windows .
- Governance: Dual Chair/CEO role and ~76% voting control provide strategic continuity but concentrate authority; majority‑independent board and independent committees provide oversight; employee directors receive no extra fees .
- Risk flags: Active securities and derivative litigation; continue monitoring disclosures and outcomes; hedging/pledging policy is robust and the prior pledge has been unwound .
- Performance trajectory: Strong FY2025 execution (above‑max revenue and adj. EBITDA) supports incentive payouts; however, cumulative TSR since IPO trails the IT peer group, an area to watch as commercial execution and capital allocation evolve .